Diagnosis and Management of Blood Diseases
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Hematology".
Deadline for manuscript submissions: 30 July 2024 | Viewed by 25831
Special Issue Editors
Interests: immune thrombocytopenia purpura; hemophilia; von Willebrand disease; rare bleeding disorders; sickle cell disease; hereditary hemorrhagic telangiectasia
2. National Bleeding Disorders Foundation, New York, NY, USA
Interests: bleeding disorders; pediatric hematology/oncology; hemophilia; thrombosis; data collection and curation; databases
Special Issue Information
Dear Colleagues,
Non-malignant hematologic conditions are receiving more attention from academic and biotechnology organizations as their underlying molecular mechanisms are elucidated, leading to advanced-therapy medicinal products (ATMPs) and individualized medicines with curative intent. This Special Issue of the Journal of Clinical Medicine will focus on innovations in the diagnosis, treatment, and ultimately prevention of non-malignant hematological conditions. We welcome the submission of original research and review articles presenting results in the above-mentioned research fields, as well as papers discussing findings of pre-clinical studies and clinical trials.
Potential topics include (but are not limited to) the following:
- Immune thrombocytopenia purpura;
- hemophilia;
- von Willebrand Disease;
- Rare bleeding disorders;
- Sickle Cell Disease;
- hereditary hemorrhagic telangiectasia;
- Thrombotic disorders;
- Quality improvement in beneign hematology;
- Database soultions to monitor and track people with these disorders
Dr. Leonard A. Valentino
Dr. Michael Recht
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Immune thrombocytopenia purpura
- hemophilia
- von Willebrand Disease
- Rare bleeding disorders
- Sickle Cell Disease
- hereditary hemorrhagic telangiectasia
- Thrombotic disorders
- Quality improvement in benign hematology
- Database solutions to monitor and track people with these disorders